Evidence map›Paper›PMID 37027536›Full record

ArticleNeuroImmune pharmacology and therapeutics2023

The link between chronic cocaine use, B cell perturbations, and blunted immune recovery in HIV-infected individuals on suppressive ART.

Da Cheng, Zhenwu Luo, Sylvia Fitting, William Stoops, Sonya L Heath, Lishomwa C Ndhlovu, Wei Jiang

Open access · hybridAbstract read
In one paragraph

Article in NeuroImmune pharmacology and therapeutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Systemic translocation ofJournal of virology · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Da ChengDepartment of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, USA.
Zhenwu LuoDepartment of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, USA.
Sylvia FittingDepartment of Psychology & Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
William StoopsDepartment of Behavioral Science, Department of Psychiatry, Center on Drug and Alcohol Research, Department of Psychology, University of Kentucky College of Medicine and College of Arts and Sciences, Lexington, KY, USA.
Sonya L HeathDepartment of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA.
Lishomwa C NdhlovuDepartment of Medicine, Division of Infectious Diseases, Weill Cornell Medicine, New York, NY, USA.
Wei JiangDepartment of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, USA.
Medical University of South Carolina · USCornell University · USUniversity of Alabama at Birmingham · USUniversity of Kentucky · USUniversity of North Carolina at Chapel Hill · US

Funding

Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Paul A. Goepfert · 1988 to 2026
$84.1M
Development of Brain Organoids to Study the Impact of HIV-1, Drugs of Abuseand Aging on Cognitive ImpairmentR01DA052027 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI NDHLOVU, LISHOMWA C, NIXON, DOUGLAS F · 2020 to 2024
$3.7M
Investigating the effect of oral microbiome on cognition in HIV-infected chronic cannabis usersR01DA055523 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Sylvia Fitting, Wei Jiang · 2022 to 2026
$3.5M
Cardiovascular, Immune and Psychosocial Benefits of Reduced Cocaine UseR01DA043938 · NIDA · UNIVERSITY OF KENTUCKY · PI STOOPS, WILLIAM WALTON · 2017 to 2022
$2.9M
Endocannabinoid-mediated neuroprotection in models of neuroAIDS in vivoR01DA045596 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FITTING, SYLVIA · 2018 to 2022
$1.9M
Investigate B cell perturbations and immune reconstitution failure in response to antiretroviral therapy in HIV-infected cocaine usersR03DA057164 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI JIANG, WEI · 2022 to 2023
$302k
Investigate the mechanism of autoreactive B cell-mediated immunological failure despite virologic suppression in HIV-infected individuals on antiretroviral therapyI01CX002422 · VA · RALPH H JOHNSON VA MEDICAL CENTER · PI Wei Jiang · 2022 to 2026
–
CSRD VA I01 CX002422NIAID NIH HHS P30 AI027767NIDA NIH HHS R01 DA043938NIDA NIH HHS R01 DA045596NIDA NIH HHS R01 DA052027NIDA NIH HHS R01 DA055523NIDA NIH HHS R03 DA057164
6 · The paper itself

Abstract

Background: We recently reveal that anti-CD4 autoantibodies contribute to blunted CD4+ T cell reconstitution in HIV+ individuals on antiretroviral therapy (ART). Cocaine use is common among HIV+ individuals and is associated with accelerated disease progression. However, the mechanisms underlying cocaine-induced immune perturbations remain obscure. Methods: We evaluated plasma levels of anti-CD4 IgG and markers of microbial translocation, as well as B-cell gene expression profiles and activation in HIV+ chronic cocaine users and non-users on suppressive ART, as well as uninfected controls. Plasma purified anti-CD4 IgGs were assessed for antibody-dependent cytotoxicity (ADCC). Results: HIV+ cocaine users had increased plasma levels of anti-CD4 IgGs, lipopolysaccharide (LPS), and soluble CD14 (sCD14) versus non-users. An inverse correlation was observed in cocaine users, but not non-drug users. Anti-CD4 IgGs from HIV+ cocaine users mediated CD4+ T cell death through ADCC Conclusions: This study improves our understanding of cocaine associated B cell perturbations and immune failure and the new appreciation for autoreactive B cells as novel therapeutic targets.

Indexed as

antibody-dependent cytotoxicityanti-CD4 IgGantiretroviral therapyCD4+ T cell recoverycocaineHIV

Identifiers

PMID37027536
PMCPMC10070012
OpenAlexW4360822150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.